| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/07/2005 | CN1665482A Methods and dosage forms for controlled delivery of oxycodone |
| 09/07/2005 | CN1663610A Lysozyme preparation |
| 09/07/2005 | CN1663607A Antisenescence medicine |
| 09/07/2005 | CN1663602A Medicine for treating neurasthenia |
| 09/07/2005 | CN1663600A Compound preparation composed of ginkgo leaf extracts and medicines promoting cerebral metabolism and its application |
| 09/07/2005 | CN1663587A Externally applied ointment |
| 09/07/2005 | CN1663578A Application of liquorice glycoside in preparing drugs for preventing and/or treating depression |
| 09/07/2005 | CN1663563A Compound troxerutin and piracetam formulation and application thereof |
| 09/07/2005 | CN1217955C Live scorpion active protein having anti-epilepsy function, preparing method and use |
| 09/07/2005 | CN1217952C Compound |
| 09/07/2005 | CN1217945C CRF receptor antagonists and methods relating thereto |
| 09/07/2005 | CN1217943C New use and novel N-azabicyclo-amide derivatives |
| 09/07/2005 | CN1217938C Bis-arylsulfones |
| 09/07/2005 | CN1217926C Novel vitamin D analogues |
| 09/07/2005 | CN1217920C Compounds to treat Alzheimer disease |
| 09/07/2005 | CN1217918C Aminocyclohexyl ether compounds and uses thereof |
| 09/07/2005 | CN1217682C Medicine for treating epilepsis |
| 09/07/2005 | CN1217659C Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 09/06/2005 | US6939992 Polymorphic forms of sertraline hydrochloride |
| 09/06/2005 | US6939990 Derivatives of dicarboxylic acid having pharmaceutical properties |
| 09/06/2005 | US6939989 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 09/06/2005 | US6939894 Methods for reducing excessive barking of a dog |
| 09/06/2005 | US6939891 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 09/06/2005 | US6939886 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 09/06/2005 | US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 09/06/2005 | US6939876 Mixture of analgesic and addition reducting compound of a gamma-aminobutyric acid |
| 09/06/2005 | US6939871 Central nervous system disorders including depression and/or anxiety; 5-HT1 type receptor and/or serotonin reuptake inhibition activity |
| 09/06/2005 | US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents |
| 09/06/2005 | US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
| 09/06/2005 | US6939570 Composition and methods for treating Alzheimer's disease and other amyloidoses |
| 09/06/2005 | US6939559 Pharmaceutical composition for application to mucosa |
| 09/06/2005 | US6939539 present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons |
| 09/06/2005 | CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them |
| 09/06/2005 | CA2127536C Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists |
| 09/05/2005 | CA2460602A1 Pancreatic multipotent progenitor cells |
| 09/01/2005 | WO2005080976A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia |
| 09/01/2005 | WO2005080435A1 Monoclonal antibody and use thereof |
| 09/01/2005 | WO2005080394A1 4-substituted piperidine derivatives |
| 09/01/2005 | WO2005080385A1 Indanol derivative |
| 09/01/2005 | WO2005079830A1 Inhibitors of amyloid fibril formation and uses thereof |
| 09/01/2005 | WO2005079789A1 Combinatorial therapy with an acetylcholinesterase inhibitor and (3ar)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate |
| 09/01/2005 | WO2005079788A1 Amino alcohol compound |
| 09/01/2005 | WO2005079780A1 Amidine derivatives for treating amyloidosis |
| 09/01/2005 | WO2004103394B1 Method and compositions for nerve regeneration |
| 09/01/2005 | WO2004089353A8 Methods for treatment of parkinson's disease |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050192343 Nerve growth factor activity potentiating agents |
| 09/01/2005 | US20050192336 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 09/01/2005 | US20050192335 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 09/01/2005 | US20050192334 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 09/01/2005 | US20050192332 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 09/01/2005 | US20050192327 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 09/01/2005 | US20050192326 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 09/01/2005 | US20050192318 5-[4-Methylsulfonyloxy-2-(S)-(3,4-dichlorophenyl)butyl]-10-cyano-3-(R)-methyl-6-oxo-3,4,5,6-tetrahydro-2H-benzo[b][1,5]oxazocine as antidepressant |
| 09/01/2005 | US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/01/2005 | US20050192309 Method of preventing abuse of opioid dosage forms |
| 09/01/2005 | US20050192308 N-but-E-enyl norbuprenorphine and methods of use |
| 09/01/2005 | US20050192307 Benzimidazolone compounds |
| 09/01/2005 | US20050192306 Pyrimidine derivatives as selective inhibitors of COX-2 |
| 09/01/2005 | US20050192304 Rho-kinase inhibitors |
| 09/01/2005 | US20050192259 A sustained release formulation of an aldosterone antagonist orally administered about 6-12 hours prior to the acrophase to provide a profile of plasma drug concentration corresponding to the diurnal cycle of plasma aldosterone concentration; hypotensive agents; circadi rhythm; cardiovascular disorders |
| 09/01/2005 | US20050192238 Modulation of the expression of genes dependent on stat-1 |
| 09/01/2005 | US20050192218 For producing analgesia in a mammalian subject |
| 09/01/2005 | US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation |
| 09/01/2005 | US20050191747 Recombinant bovine immunodeficiency virus based gene transfer system |
| 09/01/2005 | US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders |
| 09/01/2005 | US20050191650 Used to reduce body temperature, suppress appetite, and therapy or prophylaxis of congestive heart failure and various stress-related disorders |
| 09/01/2005 | US20050191649 Identifying mutation in oligoadenylate synthetase gene (OAS1); identifying modulators for prevention and treatment of cell proliferative, nervous system and diabetic disorders |
| 09/01/2005 | US20050191641 Nucleotide sequences coding hydrolase for use as tool in identifying modulators for prevention and treatment of digestion, coagulation, diabetic, cell proliferative, urogenital, eating and nervous system gynecological disorders |
| 09/01/2005 | US20050191617 Pramyxovirusl vectors encoding antibody and utilization thereof |
| 09/01/2005 | US20050191354 Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent |
| 09/01/2005 | US20050191348 Neurodegenerative disease, dementia, affective or mood disorder, drug use and dependence, memory loss disorder, acute neurological traumatic disorder or neurotrauma |
| 09/01/2005 | US20050191314 vaccine comprosing a mixture of A beta oligomers capable of generating an immune response; prophylaxis and treatment of Alzheimer's disease |
| 09/01/2005 | US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 09/01/2005 | US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 09/01/2005 | US20050191292 of reversing cognitive decline by administering a humanized antibody that binds to A beta; particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease or Down's syndrome. |
| 09/01/2005 | US20050191275 Method for short-term and long-term drug dosimetry |
| 09/01/2005 | CA2816904A1 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
| 09/01/2005 | CA2559398A1 Pyrrole-3-carboxamide derivatives for the treatment of obesity |
| 09/01/2005 | CA2558770A1 Use of tweak modulators and inhibitors for the treatment of neurological conditions |
| 09/01/2005 | CA2557539A1 Indanol derivative |
| 09/01/2005 | CA2557158A1 Prophylactic antimigraine agents |
| 09/01/2005 | CA2556589A1 4-substituted piperidine derivatives |
| 09/01/2005 | CA2556424A1 Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites |
| 09/01/2005 | CA2556268A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists |
| 09/01/2005 | CA2556263A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 09/01/2005 | CA2556214A1 Combination of an nmda receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other cns disorders |
| 09/01/2005 | CA2555970A1 Therapeutic amide derivatives |
| 09/01/2005 | CA2555399A1 Dpp-iv inhibitors for treating neurodegeneration and cognitive disorders |
| 09/01/2005 | CA2555386A1 Use of cholinesterase inhibitors for treating vascular depression |
| 09/01/2005 | CA2555272A1 Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 09/01/2005 | CA2555263A1 Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands |
| 09/01/2005 | CA2555236A1 Methods of modulating cytokine activity; related reagents |
| 09/01/2005 | CA2555084A1 Combinatorial therapy with an acetylcholinesterase inhibitor and (3ar)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate |
| 09/01/2005 | CA2554894A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists |
| 09/01/2005 | CA2554774A1 Novel heterocyclic compound |
| 09/01/2005 | CA2554090A1 Triazole derivatives which inhibit vasopressin antagonistic activity |
| 09/01/2005 | CA2552094A1 Amidine derivatives for treating amyloidosis |
| 09/01/2005 | CA2537079A1 Fluorene derivative |
| 09/01/2005 | CA2498966A1 Novel pyrazole analogs acting on cannabinoid receptors |